These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
444 related articles for article (PubMed ID: 34416053)
21. Relapse of class V lupus nephritis after vaccination with COVID-19 mRNA vaccine. Tuschen K; Bräsen JH; Schmitz J; Vischedyk M; Weidemann A Kidney Int; 2021 Oct; 100(4):941-944. PubMed ID: 34352310 [No Abstract] [Full Text] [Related]
22. Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients. Benotmane I; Gautier-Vargas G; Cognard N; Olagne J; Heibel F; Braun-Parvez L; Martzloff J; Perrin P; Moulin B; Fafi-Kremer S; Caillard S Kidney Int; 2021 Jun; 99(6):1487-1489. PubMed ID: 33775674 [No Abstract] [Full Text] [Related]
23. Adverse Events Following One Dose of mRNA COVID-19 Vaccination Among US Nursing Home Residents With and Without a Previous SARS-CoV-2 Infection. Bardenheier BH; Gravenstein S; Blackman C; Gutman R; Sarkar IN; Feifer RA; White EM; McConeghy K; Nanda A; Bosco E; Mor V J Am Med Dir Assoc; 2021 Nov; 22(11):2228-2232. PubMed ID: 34534492 [TBL] [Abstract][Full Text] [Related]
31. Immunogenicity of a first dose of mRNA- or vector-based SARS-CoV-2 vaccination in dialysis patients: a multicenter prospective observational pilot study. Lesny P; Anderson M; Cloherty G; Stec M; Haase-Fielitz A; Haarhaus M; Santos C; Lucas C; Macario F; Haase M J Nephrol; 2021 Aug; 34(4):975-983. PubMed ID: 34050904 [TBL] [Abstract][Full Text] [Related]
32. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021. Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519 [TBL] [Abstract][Full Text] [Related]
33. New insights into Covid-19 disease. Apo-A1 antibodies are generated after mRNA Covid-19 vaccination and after Covid-19 infection. Twickler DTM Eur J Clin Invest; 2022 Feb; 52(2):e13729. PubMed ID: 34921724 [No Abstract] [Full Text] [Related]
34. Effectiveness of mRNA COVID-19 vaccines in preventing SARS-CoV-2 infections and COVID-19 hospitalisations and deaths in elderly long-term care facility residents, Spain, weeks 53 2020 to 13 2021. Mazagatos C; Monge S; Olmedo C; Vega L; Gallego P; Martín-Merino E; Sierra MJ; Limia A; Larrauri A; ; Euro Surveill; 2021 Jun; 26(24):. PubMed ID: 34142647 [TBL] [Abstract][Full Text] [Related]
35. Single Dose of an mRNA Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) Vaccine Is Associated With Lower Nasopharyngeal Viral Load Among Nursing Home Residents With Asymptomatic Coronavirus Disease 2019 (COVID-19). McEllistrem MC; Clancy CJ; Buehrle DJ; Lucas A; Decker BK Clin Infect Dis; 2021 Sep; 73(6):e1365-e1367. PubMed ID: 33768222 [TBL] [Abstract][Full Text] [Related]
38. Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine. Benotmane I; Gautier-Vargas G; Cognard N; Olagne J; Heibel F; Braun-Parvez L; Martzloff J; Perrin P; Moulin B; Fafi-Kremer S; Caillard S Kidney Int; 2021 Jun; 99(6):1498-1500. PubMed ID: 33887315 [No Abstract] [Full Text] [Related]
39. Note for "Ramsay Hunt syndrome and mRNA SARS-COV-2 vaccination". Rodríguez-Martín M Enferm Infecc Microbiol Clin (Engl Ed); 2022 Jan; 40(1):49. PubMed ID: 34920987 [No Abstract] [Full Text] [Related]
40. Important Insights into Myopericarditis after the Pfizer mRNA COVID-19 Vaccination in Adolescents. Long SS J Pediatr; 2021 Nov; 238():5. PubMed ID: 34332972 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]